With B buyout wrapped, Mylan plans to shutter Meda’s U.S. headquarters, cut 94 jobs With $7B buyout wrapped, Mylan plans to shutter Meda’s U.S. headquarters, cut 94 jobs esagonowsky Mon, […]
Takeda CEO says new myeloma drug Ninlaro will be ‘significantly bigger than Velcade’ Takeda CEO says new myeloma drug Ninlaro will be ‘significantly bigger than Velcade’ phil Mon, 10/31/2016 – […]
Novo Nordisk kills oral insulin, rejigs R&D to address U.S. payers Novo Nordisk kills oral insulin, rejigs R&D to address U.S. payers slawrence Mon, 10/31/2016 – 10:19 Source: FierceMedicalDevices […]
Sanofi/Regeneron hit with FDA delay for sarilumab Sanofi/Regeneron hit with FDA delay for sarilumab badams Mon, 10/31/2016 – 04:45 Source: FierceMedicalDevices News Sanofi/Regeneron hit with FDA delay for sarilumab
‘Poor’ Humira performance triggers Q3 sales miss for AbbVie, but SG&A beat keeps EPS in line ‘Poor’ Humira performance triggers Q3 sales miss for AbbVie, but SG&A beat keeps EPS […]
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness tracy Fri, 10/28/2016 – 11:00 […]
Astellas snaps up cancer antibody play Ganymed for up to .4B Astellas snaps up cancer antibody play Ganymed for up to $1.4B slawrence Fri, 10/28/2016 – 10:10 Source: FierceMedicalDevices […]
Tesaro’s PARP accepted for review in EU as AZ makes case for Lynparza Tesaro’s PARP accepted for review in EU as AZ makes case for Lynparza badams Fri, 10/28/2016 – […]
AstraZeneca down on partial hold for PhIII PD-L1 candidate AstraZeneca down on partial hold for PhIII PD-L1 candidate slawrence Thu, 10/27/2016 – 15:10 Source: FierceMedicalDevices News AstraZeneca down on […]
Amazon’s Bezos, Mayo Clinic back Unity in 6M Series B to slow diseases of aging Amazon’s Bezos, Mayo Clinic back Unity in $116M Series B to slow diseases of aging […]